Filter
5875
Filtered Results: 5875
Text search:
Public
Health
Surveillance
Featured
Recommendations
534
New Publications
1577
Language
Document type
No document type
2987
Studies & Reports
1069
Guidelines
885
Strategic & Response Plan
343
Manuals
262
Fact sheets
131
Situation Updates
88
Training Material
70
Resource Platforms
14
Infographics
13
Brochures
8
Online Courses
5
Countries / Regions
Global
247
India
186
Kenya
147
Sierra Leone
140
Liberia
132
Western and Central Europe
124
Ethiopia
119
Africa
117
Congo, Democratic Republic of
112
Latin America and the Carribbean
111
Nigeria
107
South Africa
97
Uganda
92
Malawi
86
Nepal
83
Senegal
77
Rwanda
74
Guinea
70
Bangladesh
70
Zambia
66
Syria
63
Tanzania
63
Ghana
62
Ukraine
60
Burkina Faso
56
Myanmar / Burma
55
West and Central Africa
52
Eastern Europe
50
South–East Asia Region
45
Philippines
44
Russia
44
Benin
43
Haiti
41
South Sudan
40
Mozambique
38
East and Southern Africa
38
Namibia
38
Brazil
36
Middle East and North Africa
35
Zimbabwe
34
Asia
34
Yemen
33
Madagascar
32
Cambodia
29
Indonesia
28
Cameroon
27
Germany
27
Mali
25
Pakistan
25
Lesotho
22
Eastern Europe and Central Asia
21
Côte d’Ivoire / Ivory Coast
21
Botswana
20
Colombia
18
Niger
17
Venezuela
16
Western Pacific Region
16
Central African Republic
16
Afghanistan
15
Eswatini/ Swaziland
15
Sudan
14
Tajikistan
13
Somalia
13
Togo
12
Albania
11
North America
11
Moldova
11
Thailand
10
USA
10
Angola
10
Chad
10
Burundi
9
Jordan
9
Paraguay
9
Argentina
9
Lebanon
9
Vietnam
8
Georgia
8
Iraq
8
Ecuador
8
Turkey
7
China
7
Peru
7
Papua New Guinea
7
North Macedonia
6
Laos
6
Guinea-Bissau
6
Ireland
6
Bolivia
6
Palestine
6
Timor Leste/ East Timor
5
Mexico
5
Gambia
5
Chile
5
Iran
5
Morocco
5
Libya
5
Armenia
4
Saudi Arabia
4
France
4
Tunisia
4
Spain
4
Southern Africa
4
Sri Lanka
4
Kazakhstan
3
Kyrgyzstan
3
Qatar
3
Mauritania
3
Turkmenistan
3
Mauritius
3
Belarus
3
Egypt
3
Romania
3
Honduras
3
Bhutan
3
North Korea
2
Congo-Brazzaville
2
Uzbekistan
2
Bulgaria
2
Italy
2
Dominican Republic
2
Gabon
2
Belgium
2
Portugal
2
Israel
2
Bosnia and Herzegovina
2
Greece
2
Switzerland
1
El Salvador
1
Serbia
1
Australia
1
Fiji
1
Singapore
1
Estonia
1
Vanuatu
1
Cape Verde
1
Hungary
1
Japan
1
Denmark
1
Maldives
1
United Kingdom
1
Azerbaijan
1
Nicaragua
1
Djibouti
1
Slovakia
1
Poland
1
Solomon Islands
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
2225
Clinical Guidelines
469
Public Health
325
Key Resources
311
Women & Child Health
199
Pharmacy & Technologies
81
Capacity Building
60
Toolboxes
COVID-19
694
HIV
455
TB
386
Rapid Response
324
AMR
307
Ebola & Marburg
266
NTDs
257
Planetary Health
194
Mental Health
191
Conflict
117
Caregiver
107
Zika
86
NCDs
85
Global Health Education
83
Refugee
80
Pharmacy
75
Natural Hazards
74
Cholera
71
Polio
61
Disability
49
Health Financing Toolbox
45
Specific Hazards
31
Malaria
20
Social Ethics
6
Typhoon
3
L’Assemblée mondiale de la Santé, tenue en mai 2015, a adopté un Plan d’action mondial pour combattre la résistance aux antimicrobiens, qui définit 5 objectifs:
mieux faire connaître et comprendre le problème de la résistance aux antimicrobiens grâce à une communication, une éduc...
Le présent document rassemble une série de recommandations émises par l’Organisation mondiale de la Santé (OMS) et l’Organisation panaméricaine de la Santé (OPS) pour aider les professionnels chargés des programmes de lutte antivectorielle en Amérique latine et dans les Caraïbes aux niv...
Les maladies concernées sont les schistosomiases, les géohelminthiases, la lèpre, la rage, la dengue, la leishmaniose, le mycétome, et les envenimassions par morsure de serpents. Tout comme plusieurs autres pays, la Mauritanie se trouve actuellement à un stade où le trachome n'est plus c...
Avec l’essor des traitements antirétroviraux (TAR) à base de dolutégravir (DTG) pour soigner les personnes vivant avec
le VIH dans le monde, il est important d’estimer la vitesse à laquelle la résistance acquise au DTG apparaît dans les
populations sous TAR. Bien que la résistance au DT...
La carga de la diabetes es enorme, posicionándola como uno de los principales desafíos que enfrenta la salud pública en la actualidad. Actualmente, se estima que 62 millones de personas viven con diabetes en la Región de las Américas y las proyecciones muestran que su prevalencia seguirá aumen...
These guidelines provide a recommendation on iodine thyroid blocking (ITB), via oral administration of stable iodine, as an urgent protective action in responding to a nuclear accident. This recommendation aims to support emergency planners, policy makers, public health specialists, clinicians and o...
UNAIDS/WHO Working group
HIV/AIDS and STI surveillance 2015 / Reference
Cholera is an acute gastrointestinal infection caused by the bacterium Vibrio Cholerae serogroup O1 or O139, and is often linked to unsafe drinking water, lack of proper sanitation and personal hygiene. It adversely affects mostly the poor and vulnerable populations in countries, which are already d...
Notable progress has also been made on other key health indicators such as reducing maternal, infant and child deaths and malnutrition, increasing immunization coverage, eliminating infectious diseases such as polio and reducing the incidence of malaria, tuberculosis and diarrhoeal diseases.
But ...
Following the publication of Guidelines on certification of elimination of human onchocerciasis in 2001 by the World Health Organization (WHO), these are the first evidence-based guidelines developed by NTD Department according to the international standards. They provide a set of recommendations th...
This action plan is intended for senior-level decision-makers in ministries of health, malaria
programme managers, entomologists, and epidemiologists working on malaria and other vectorborne diseases programmes. It is also intended for decision-makers and technical and advocacy
staff at other orga...
UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance
This interim guidance is aimed at assisting organizers of international meetings attended by individuals from EVD-affected countries and individuals with a travel history to EVD-affected countries within the previous 3 weeks.
The first part is intended for organizers of international meetings, to ...
The goal of this Global Action Plan is to articulate synergistic actions that will be required to prevent HIVDR from undermining efforts to achieve global targets on health and HIV, and to provide the most effective treatment to all people living with HIV including adults, key populations, pregnant ...
These consolidated guidelines on HIV testing services (HTS) bring together existing and new guidance on HTS across different settings and populations.
The World Health Organization (WHO) first released consolidated guidelines on HTS in 2015, in response to requests from Member States, national pr...
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resistant TB (XDRTB) has also been reported from s...
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la...
Small drinking-water supplies commonly experience operational, managerial, technical and resourcing challenges that impact their ability to deliver safe and reliable services. The needs and opportunities associated with these supplies therefore warrant explicit consideration in policies and regulati...
Emergency medical teams (EMT) are first response health care providers – doctors, nurses, paramedics, and others – during outbreaks and emergencies or disasters, working with governments, charities such as nongovernmental organizations (NGOs), armies, and international organizations such as the ...
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) how virulent the variant is compared to other varian...
